Main content

US drug companies and the NHS

Is Britain's health service really up for sale?

Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the Βι¶ΉΤΌΕΔ's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.

(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)

Available now

18 minutes

Last on

Mon 9 Dec 2019 13:32GMT

Broadcasts

  • Mon 9 Dec 2019 08:32GMT
  • Mon 9 Dec 2019 13:32GMT

Business Daily Podcast

Download every programme.

Podcast